Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Faerm Michael E.
Viracta Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Faerm Michael E.
Viracta Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Burcar Melody
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rothera Mark
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Darrel P.
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chevallard Daniel R.
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROYSTON IVOR
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pomerantz Roger
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chevallard Daniel R.
Viracta Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Forward Ventures V, L.P.(6.65%)
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rothera Mark
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chevallard Daniel R.
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROYSTON IVOR
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pomerantz Roger
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROYSTON IVOR
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pomerantz Roger
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chevallard Daniel R.
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pomerantz Roger
Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Darrel P.
Viracta Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Cohen Darrel P.
No Data